• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚疟疾的流行病学与防控

Epidemiology and control of malaria in Malaysia.

作者信息

Mak J W, Jegathesan M, Lim P K, Hakim S L, Rain A N, Ambu S, Chong H K

机构信息

Institute for Medical Research, Kuala Lumpur, Malaysia.

出版信息

Southeast Asian J Trop Med Public Health. 1992 Dec;23(4):572-7.

PMID:1298064
Abstract

In spite of more than 30 years of control activities, malaria continues to be the most important parasitic infection in Malaysia, accounting for 39,189 confirmed cases in 1991, giving an annual parasite incidence rate of 2.2 per 1,000 population. Some factors contributing to the continued transmission of malaria are the development of drug resistant Plasmodium falciparum, changes in vector behavior, and ecological changes due to socio-economic reasons. Malaria parasite rates are higher among the Aborigines, land scheme settlers and those in intimate contact with the jungle, like loggers. There has been no substantial change in the proportion of the three common malaria species responsible for infections, P. falciparum, P. vivax, P. malariae and mixed infections accounting for about 70%, 28%, 1% and 1%, respectively of all infections. Drug resistant P. falciparum is unevenly distributed in Malaysia, but based on clinical experience and in vitro drug sensitivity studies, chloroquine resistance is frequently encountered. There has been clinical and laboratory evidence of resistance to sulfadoxine/pyrimethamine combination as well as quinine, but all these have so far been successfully treated with a combination of quinine and tetracycline. The eradication of the disease is impossible in the near future but there is confidence that with better surveillance techniques and the use of alternative control measures like permethrin impregnated bed-nets to complement existing ones, the target of bringing down the annual parasite incidence to 2 per 1,000 population during the Sixth Malaysian Plan period (1991-1995) can be achieved.

摘要

尽管开展了30多年的防治活动,但疟疾仍是马来西亚最重要的寄生虫感染疾病。1991年确诊病例达39,189例,年寄生虫发病率为每1000人2.2例。导致疟疾持续传播的一些因素包括抗药恶性疟原虫的出现、病媒行为的改变以及社会经济原因引起的生态变化。原住居民、垦殖计划定居者以及与丛林密切接触的人群(如伐木工)的疟疾寄生虫感染率较高。引起感染的三种常见疟原虫种类,即恶性疟原虫、间日疟原虫、三日疟原虫以及混合感染,在所有感染病例中所占比例分别约为70%、28%、1%和1%,这一比例并无实质性变化。抗药恶性疟原虫在马来西亚的分布并不均匀,但根据临床经验和体外药敏试验,氯喹耐药情况屡见不鲜。已有临床和实验室证据表明对磺胺多辛/乙胺嘧啶合剂以及奎宁存在耐药性,但到目前为止,所有这些病例均通过奎宁和四环素联合用药成功治愈。在不久的将来根除该疾病是不可能的,但人们相信,通过采用更好的监测技术以及使用诸如经氯菊酯处理的蚊帐等替代防治措施来补充现有措施,在马来西亚第六个五年计划期间(1991 - 1995年)将年寄生虫发病率降至每1000人2例的目标是可以实现的。

相似文献

1
Epidemiology and control of malaria in Malaysia.马来西亚疟疾的流行病学与防控
Southeast Asian J Trop Med Public Health. 1992 Dec;23(4):572-7.
2
[Current malaria situation in Turkey].[土耳其当前的疟疾形势]
Med Parazitol (Mosk). 2001 Jan-Mar(1):44-5.
3
Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.巴布亚新几内亚针对恶性疟原虫、间日疟原虫和三日疟原虫的标准治疗方案的寄生虫学及临床疗效
P N G Med J. 2005 Sep-Dec;48(3-4):141-50.
4
Resurgence of malaria and drug resistance in plasmodium falciparum and plasmodium vivax species in Bombay.孟买恶性疟原虫和间日疟原虫物种中疟疾及耐药性的再度出现。
J Assoc Physicians India. 1995 May;43(5):336-8.
5
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.在巴布亚新几内亚,阿莫地喹或氯喹联合磺胺多辛-乙胺嘧啶治疗恶性疟原虫和间日疟原虫疟疾的疗效较低。
Am J Trop Med Hyg. 2007 Nov;77(5):947-54.
6
Chloroquine resistant malaria in West Malaysia.马来西亚西部的氯喹耐药性疟疾。
J Trop Med Hyg. 1975 Mar;78(3):54-8.
7
Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia.湄公河疟疾。东南亚大湄公河次区域的疟疾、多重耐药性与经济发展
Southeast Asian J Trop Med Public Health. 1999;30 Suppl 4:i-iv, 1-101.
8
Sustainability of pyrethroid-impregnated bednets for malaria control in Afghan communities.阿富汗社区中用于疟疾防控的拟除虫菊酯浸渍蚊帐的可持续性
Bull World Health Organ. 1997;75(1):23-9.
9
[Malaria in the Americas].[美洲的疟疾]
Med Trop (Mars). 1999;59(3):298-302.
10
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.在恶性疟原虫和间日疟原虫共同流行地区,磺胺多辛-乙胺嘧啶联合青蒿琥酯与氯喹治疗间日疟的疗效比较:阿富汗东部的一项随机非劣效性试验
Trans R Soc Trop Med Hyg. 2007 Nov;101(11):1081-7. doi: 10.1016/j.trstmh.2007.06.015. Epub 2007 Aug 17.

引用本文的文献

1
Exploring the key anthropological drivers of and barriers to zoonotic malaria preventative behaviour in a community exposed to infection in Malaysia: protocol for a qualitative study with a participatory research design.探索马来西亚某社区中人类对动物源疟疾病原体预防行为的关键人类学驱动因素和障碍:一项采用参与式研究设计的定性研究方案。
BMJ Open. 2022 Jun 30;12(6):e060866. doi: 10.1136/bmjopen-2022-060866.